VAERS reports by lot

Pfizer Pneumococcal lot GT6701: VAERS reports

32 VAERS reports list lot GT6701 as a Pfizer Pneumococcal vaccine, received between 2023-07-07 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
32
Reports
9%
Marked serious
1
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction5141%
General / Systemic (non-local)1512%
Cardiac / Cardiovascular1210%
Neurological97%
Gastrointestinal76%
Musculoskeletal76%
Allergic / Anaphylactic65%
Dermatological (non-injection-site)65%
Respiratory54%
Thrombotic / Hematological43%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York3
Michigan3
Florida2
Washington2
Massachusetts2
California2
District of Columbia1
Arkansas1
Illinois1
New Mexico1
Maryland1
North Carolina1

Reports by month received

2023-072
2023-088
2023-096
2023-103
2023-112
2024-012
2024-041
2024-068

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.